Stage IIIB Skin Melanoma Completed Phase 2 Trials for Menthol (DB14123)
Indication | Status | Phase |
---|---|---|
DBCOND0029534 (Stage IIIB Skin Melanoma) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00397982 | Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma | Treatment |